With the nadir of the supply chain crisis and factory closures in the rearview mirror, Crocs is amping back up product newness and international growth as its customers seem immune thus far to recessionary pressure. The company reported positive quarter-to-date results at UBS’ investor conference boosted by new product introductions, continuing the newness momentum from the H2 of 2022. This is reinvigorating CROX’s plans to push sandals sales, translating to a 29% growth guide to $400 million for FY ’23, particularly in year-round markets such as India and Southeast Asia. Meanwhile, ... Log in to view full article.